86 related articles for article (PubMed ID: 6489904)
41. [Recurrence prevention of papillomas of the bladder using lycurim instillation].
Zárandy B; Szabó J; Molnár I; Sallai Z; Simon Z; Légrády J
Z Urol Nephrol; 1984 Oct; 77(10):599-603. PubMed ID: 6549094
[TBL] [Abstract][Full Text] [Related]
42. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor].
Ikegami S; Tsuji A; Suzuki S; Sumitomo M; Kimura F; Asano T; Nakajima F; Hayakawa M
Hinyokika Kiyo; 1999 May; 45(5):325-9. PubMed ID: 10410314
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
44. [A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer].
Miki T; Nonomura N; Kojima Y; Okuyama A; Nakano E; Kiyohara H; Fujioka H; Koide T; Wakatsuki A; Kuroda H; Sugao H; Seguti T; Takeyama M; Yamaguchi S
Hinyokika Kiyo; 1997 Dec; 43(12):907-12. PubMed ID: 9488944
[TBL] [Abstract][Full Text] [Related]
45. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
Herr HW; Sogani PC
J Urol; 2001 Oct; 166(4):1296-9. PubMed ID: 11547061
[TBL] [Abstract][Full Text] [Related]
46. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
[TBL] [Abstract][Full Text] [Related]
47. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
48. [Value of long-term prevention in noninvasive bladder tumors].
Burk K; Droller RM; Pittner P
Helv Chir Acta; 1985 Sep; 52(3-4):473-5. PubMed ID: 3905716
[No Abstract] [Full Text] [Related]
49. [Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].
Liberti M; Tenaglia R; De Berardinis E; Gentile V
Minerva Med; 1984 Feb; 75(8):391-4. PubMed ID: 6424059
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant intravesical chemotherapy of superficial bladder cancer with monthly doxorubicin or intensive mitomycin. A comparison of two consecutive series.
Ausfeld R; Beer M; Mühlethaler JP; Bartlome F; Widmer R; Tscholl R
Eur Urol; 1987; 13(1-2):10-4. PubMed ID: 3582437
[TBL] [Abstract][Full Text] [Related]
51. [Comparative study of 62 patients randomly treated with adriamycin or cisplatin as chemoprophylaxis of their superficial bladder carcinoma].
Iborra Juan I; Monrós Lliso JL; Ricós Torrent JV; Mazcuñan Fuentes F; Casanova Ramón-Borja J; Solsona Narbón E
Actas Urol Esp; 1988; 12(1):20-4. PubMed ID: 3389211
[No Abstract] [Full Text] [Related]
52. Topical doxorubicin hydrochloride therapy for carcinoma in situ of the bladder: a followup.
Jakse G; Hofstädter F; Marberger H
J Urol; 1984 Jan; 131(1):41-2. PubMed ID: 6690744
[TBL] [Abstract][Full Text] [Related]
53. Further comments on 1744 bladder tumors.
Cifuentes Delatte L; García de la Peña E; Vela Navarrete R
Prog Clin Biol Res; 1984; 162A():301-5. PubMed ID: 6435134
[No Abstract] [Full Text] [Related]
54. Selective chemoprophylaxis guided by multifactorial analysis in superficial bladder cancer.
Vera-Donoso CD; Llopis B; Oliver F; Gallego J; Ruiz J; Vidal J; Jiménez Cruz JF
Eur Urol; 1990; 17(3):219-22. PubMed ID: 2112473
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant chemotherapy for bladder cancer with doxorubicin hydrochloride and cyclophosphamide: preliminary report.
Merrin C; Beckley S
J Urol; 1978 Jan; 119(1):62-3. PubMed ID: 621817
[TBL] [Abstract][Full Text] [Related]
56. Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin and urokinase.
Lundbeck F; Mogensen P; Jeppesen N
J Urol; 1983 Dec; 130(6):1087-9. PubMed ID: 6644887
[TBL] [Abstract][Full Text] [Related]
57. Adjuvant chemotherapy following radical radiotherapy in T3 bladder carcinoma.
Richards B; Akdas A; Crobett P; Glashan RW; Robinson MR; Smith PA
Recent Results Cancer Res; 1978; 68():334-7. PubMed ID: 752869
[No Abstract] [Full Text] [Related]
58. [Not Available].
Rexer H
Aktuelle Urol; 2015 Jul; 46(4):282-3. PubMed ID: 26227124
[No Abstract] [Full Text] [Related]
59. [Treatment of deep tumors of the bladder (1st series)].
Zadaire Bergera JJ; Urmeneta Sanromá JM; Robles García JE; Ponz González M; Luzuriaga Graf J; Salváverd A; Berián Polo JM
Actas Urol Esp; 1985; 9(1):69-72. PubMed ID: 4013848
[No Abstract] [Full Text] [Related]
60. On the local treatment of urinary bladder tumours with peptichemio.
Battelli T; Bonsignori M; Manocchi P; Perilli A; Lombardi R
Panminerva Med; 1975; 17(7-8):262-4. PubMed ID: 1161332
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
